<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02121743</url>
  </required_header>
  <id_info>
    <org_study_id>PI2014_843_0001</org_study_id>
    <secondary_id>2013-A01461-44</secondary_id>
    <nct_id>NCT02121743</nct_id>
  </id_info>
  <brief_title>Use of a Biological Mesh (StratticeTM) for the Prevention of Parastomal Hernia After Colorectal Surgery With Colostomy</brief_title>
  <acronym>PROBIOCOL</acronym>
  <official_title>Prospective, Multicenter, Randomized, Parallel Group Clinical Study Evaluating the Efficacy of a Biological Mesh (StratticeTM) for the Prevention of Parastomal Hernia After Colorectal Surgery With Colostomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>LifeCell</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In France around 5,000 colostomies are performed after elective or emergency surgery. These
      colostomies could be associated with major outcomes including parastomal hernia (4 - 53%) of
      cases.

      To reduce the incidence of these outcomes, several methods have been proposed but the more
      pertinent consist in the use of a biological mesh during the stoma's conception.

      Nevertheless there is no data on the use of a biological mesh (StratticeTM) for the
      prevention of parastomal hernia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>rate of parastomal hernia</measure>
    <time_frame>postoperative month 6</time_frame>
    <description>the presence of a parastomal hernia will be diagnosed either by the clinical examination either by a CT scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>evaluation of the pain</measure>
    <time_frame>2 years after the surgery</time_frame>
    <description>The pain will be evaluated with a visual scale 1 month, 6 months, 1 year and 2 years after the surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the postoperative morbidity</measure>
    <time_frame>postoperative month 1</time_frame>
    <description>the postoperative morbidity will be assessed with the Dindo Clavien classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the parastomal hernia rate</measure>
    <time_frame>postoperative year 1</time_frame>
    <description>The parastomal hernia rate will be evaluated 1 year after the surgery during the clinical examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the quality of life</measure>
    <time_frame>2 years after the surgery</time_frame>
    <description>The quality of life will be assessed with the STOMA QoL form, the 12-Item Short Form Health Survey (SF12) and the Carolina comfort scale at 1 month, 6 months, 1 year and 2 years after the surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Parastomal Hernia</condition>
  <condition>Terminal Colostomy</condition>
  <arm_group>
    <arm_group_label>Strattice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a strattice (10 x 10) will be used during the surgery, prior to the colostomy's conception</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No strattice</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>the colostomy is not reinforced with a mesh</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>strattice</intervention_name>
    <description>use of a strattice</description>
    <arm_group_label>Strattice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>No strattice</intervention_name>
    <description>no use of a strattice</description>
    <arm_group_label>No strattice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient requiring a colorectal surgery with a terminal colostomy

          -  Elective or emergency surgery

        Exclusion Criteria:

          -  Has collagen-vascular, connective tissue, or uncorrectable bleeding disorders as
             determined clinically by the PI.

          -  Has any disease, including uncontrolled diabetes, which is clinically known to impact
             wound healing ability.

          -  Has an autoimmune disease, an immune deficiency, or is on immune suppression drugs

          -  Is pregnant, or lactating.

          -  Allergic to any porcine or collagen products.

          -  survival &lt; 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>jean marc regimbeau, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>jean marc regimbeau, MD, PhD</last_name>
    <phone>+33 3 22 66 83 00</phone>
    <email>regimbeau.jean-marc@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Amiens university hospital</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jean marc regimbeau, MD, PhD</last_name>
      <phone>+33 3 22 66 83 00</phone>
      <email>regimbeau.jean-marc@chu-amiens.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beauvais hospital</name>
      <address>
        <city>Beauvais</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>francois mauvais, MD</last_name>
      <phone>+33344112242</phone>
      <email>f.mauvais@ch-beauvais.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Caen hospital</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>arnaud alves, MD, PhD</last_name>
      <phone>+33231064470</phone>
      <email>alves-a@chu-caen.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Claude Huriet Hospital</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>christophe mariette, MD, PhD</last_name>
      <phone>+33320444407</phone>
      <email>c-mariette@chru-lille.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lariboisiere Hospital</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>marc pocard, MD, PhD</last_name>
      <phone>+33149958257</phone>
      <email>marc.pocard@lrb.ap-hop-paris.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charles Nicolle Hospital</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>jean jacques tuech, MD, PhD</last_name>
      <phone>+33232888573</phone>
      <email>jean-jacques.tuech@chu-rouen.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Timmermans L, Deerenberg EB, Lamme B, Jeekel J, Lange JF. Parastomal hernia is an independent risk factor for incisional hernia in patients with end colostomy. Surgery. 2014 Jan;155(1):178-83. doi: 10.1016/j.surg.2013.06.014. Epub 2013 Nov 12.</citation>
    <PMID>24238119</PMID>
  </reference>
  <reference>
    <citation>Lee L, Saleem A, Landry T, Latimer E, Chaudhury P, Feldman LS. Cost effectiveness of mesh prophylaxis to prevent parastomal hernia in patients undergoing permanent colostomy for rectal cancer. J Am Coll Surg. 2014 Jan;218(1):82-91. doi: 10.1016/j.jamcollsurg.2013.09.015. Epub 2013 Sep 29.</citation>
    <PMID>24210147</PMID>
  </reference>
  <reference>
    <citation>Swann JM, Turek FW. Transfer from long to short days reduces the frequency of pulsatile luteinizing hormone release in intact but not in castrated male golden hamsters. Neuroendocrinology. 1988 Apr;47(4):343-9.</citation>
    <PMID>3374759</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2014</study_first_submitted>
  <study_first_submitted_qc>April 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2014</study_first_posted>
  <last_update_submitted>May 23, 2017</last_update_submitted>
  <last_update_submitted_qc>May 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>strattice</keyword>
  <keyword>colostomy</keyword>
  <keyword>parastomal hernia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

